Rhumbline Advisers Seer, Inc. Transaction History

Rhumbline Advisers

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$1.65 - $2.24 $97,581 - $132,473	-59,140 Reduced 67.19%	28,885 $48,000
Q1 2024 May 09, 2024	BUY	$1.54 - $2.09 $5,316 - $7,214	3,452 Added 4.08%	88,025 $167,000
Q4 2023 Feb 08, 2024	BUY	$1.47 - $2.22 $767 - $1,158	522 Added 0.62%	84,573 $164,000
Q3 2023 Nov 09, 2023	BUY	$2.18 - $5.52 $5,290 - $13,397	2,427 Added 2.97%	84,051 $185,000
Q2 2023 Aug 08, 2023	BUY	$3.16 - $4.96 $12,140 - $19,056	3,842 Added 4.94%	81,624 $348,000
Q1 2023 May 11, 2023	SELL	$3.6 - $5.88 $2,030 - $3,316	-564 Reduced 0.72%	77,782 $300,000
Q4 2022 Feb 14, 2023	BUY	$5.03 - $8.58 $9,330 - $15,915	1,855 Added 2.43%	78,346 $454,000
Q3 2022 Nov 10, 2022	BUY	$7.7 - $13.31 $32,301 - $55,835	4,195 Added 5.8%	76,491 $592,000
Q2 2022 Aug 11, 2022	BUY	$6.72 - $16.07 $163,390 - $390,725	24,314 Added 50.67%	72,296 $647,000
Q1 2022 May 12, 2022	SELL	$11.88 - $23.4 $31,232 - $61,518	-2,629 Reduced 5.19%	47,982 $731,000
Q4 2021 Feb 10, 2022	BUY	$21.08 - $38.51 $2,909 - $5,314	138 Added 0.27%	50,611 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$27.67 - $45.04 $940,503 - $1.53 Million	33,990 Added 206.21%	50,473 $1.74 Million
Q2 2021 Aug 05, 2021	BUY	$28.75 - $56.92 $79,436 - $157,269	2,763 Added 20.14%	16,483 $540,000
Q1 2021 May 06, 2021	BUY	$38.67 - $84.06 $530,552 - $1.15 Million	13,720 New	13,720 $686,000

35.2M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $132M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.